Drug profile · INN
ramipril + felodipine
TRIASYN 5.0/5.0
ramipril + felodipine (TRIASYN 5.0/5.0) is an FDA-listed pharmaceutical active ingredient. Associated with Sanofi-aventis Healthcare Pty Ltd.
TGA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — ramipril + felodipine
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.81
Quick answer
ramipril + felodipine (TRIASYN 5.0/5.0) is an FDA-listed pharmaceutical active ingredient. Associated with Sanofi-aventis Healthcare Pty Ltd.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Frequently asked questions
What is ramipril + felodipine?
ramipril + felodipine (TRIASYN 5.0/5.0) is an FDA-listed pharmaceutical active ingredient. Associated with Sanofi-aventis Healthcare Pty Ltd.
What is the brand name for ramipril + felodipine?
TRIASYN 5.0/5.0 is a marketed brand name for ramipril + felodipine. Check FDA Drugs@FDA for the current US label holder and prescribing information.